ArticleRadiological physics and technology2026
Dnq-unet: a two-level fusion framework for few-shot domain adaptation in cervical cancer CTV segmentation.
Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
To develop and validate a two-level hierarchical fusion architecture enabling efficient few-shot domain adaptation for cervical cancer clinical target volume (CTV) auto-segmentation across different institutional imaging and contouring settings. We propose DNQ-UNet, a dual-encoder architecture with two fusion levels: spatially adaptive normalization (SPADE) for shallow appearance alignment and cross-attention for deep semantic transfer. A progressive two-stage training strategy with grouped learning rates was employed. Few-shot adaptation used 3, 5, 10, 20, 40, and 60 fine-tuning cases, and additional 3D fine-tuning baselines, including nnU-Net V2, SwinUNETR, and MedNeXt, were evaluated under identical target-domain test settings. Ablation studies assessed each fusion component. On the target-domain test set, zero-shot DSC was [Formula: see text]. With 3, 5, and 10 fine-tuning cases, DSC improved to [Formula: see text], [Formula: see text], and [Formula: see text], respectively. DNQ-UNet achieved the highest DSC among the compared 3D baselines at 5-shot (0.830 vs. 0.805-0.817) and 10-shot (0.838 vs. 0.823-0.833) settings. Ablation showed significant DSC reductions after removing either fusion level or using a single U-Net (all [Formula: see text]). The proposed framework enables efficient few-shot domain adaptation for cervical cancer CTV segmentation using 5-10 annotated cases, providing a locally adapted contour-initialization approach that may reduce annotation and repeated correction burden during cross-institutional deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.